Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan-R Targan

Showing results (51-60 of 181) with videos related to

Pageof 19
Sort By:
The American Surgeon|February 14, 2006
Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitisAderet Okon, Marla Dubinsky, Eric A Vasiliauskas, et al.
Diseases of the Colon and Rectum|June 17, 2010
A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitisEvan White, Gil Y Melmed, Eric A Vasiliauskas, et al.
The American Journal of Gastroenterology|October 10, 2012
Andrographis paniculata extract (HMPL-004) for active ulcerative colitisWilliam J Sandborn, Stephan R Targan, Vera S Byers, et al.
Diseases of the Colon and Rectum|June 9, 2009
A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitisZuri A Murrell, Gil Y Melmed, Andrew Ippoliti, et al.
Frontiers in Immunology|December 5, 2022
Diagnostic and therapeutic potential of RNASET2 in Crohn's disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretionEva Biener-Ramanujan, Florian Rosier, Simon G Coetzee, et al.
Inflammatory Bowel Diseases|March 16, 2016
Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal AnastomosisSharon Z Koh, Karen N Zaghiyan, Quanlin Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 7, 2004
High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapyWilliam S Mow, Maria T Abreu-Martin, Konstantinos A Papadakis, et al.
Inflammatory Bowel Diseases|January 26, 2012
Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's diseaseTravis B Murdoch, Wei Xu, Joanne M Stempak, et al.
Pharmaceutical Research|January 10, 2008
Ex vivo induction of mRNA in human whole blood as a new platform of drug and dietary supplement developmentMasato Mitsuhashi, Mieko Ogura, Katsuya Endo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cellsKonstantinos A Papadakis, John L Prehn, Carol Landers, et al.
Pageof 19

Showing results (51-60 of 181) with videos related to

Sort By:
Pageof 19
The American Surgeon|February 14, 2006
Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitisAderet Okon, Marla Dubinsky, Eric A Vasiliauskas, et al.
Diseases of the Colon and Rectum|June 17, 2010
A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitisEvan White, Gil Y Melmed, Eric A Vasiliauskas, et al.
The American Journal of Gastroenterology|October 10, 2012
Andrographis paniculata extract (HMPL-004) for active ulcerative colitisWilliam J Sandborn, Stephan R Targan, Vera S Byers, et al.
Diseases of the Colon and Rectum|June 9, 2009
A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitisZuri A Murrell, Gil Y Melmed, Andrew Ippoliti, et al.
Frontiers in Immunology|December 5, 2022
Diagnostic and therapeutic potential of RNASET2 in Crohn's disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretionEva Biener-Ramanujan, Florian Rosier, Simon G Coetzee, et al.
Inflammatory Bowel Diseases|March 16, 2016
Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal AnastomosisSharon Z Koh, Karen N Zaghiyan, Quanlin Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 7, 2004
High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapyWilliam S Mow, Maria T Abreu-Martin, Konstantinos A Papadakis, et al.
Inflammatory Bowel Diseases|January 26, 2012
Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's diseaseTravis B Murdoch, Wei Xu, Joanne M Stempak, et al.
Pharmaceutical Research|January 10, 2008
Ex vivo induction of mRNA in human whole blood as a new platform of drug and dietary supplement developmentMasato Mitsuhashi, Mieko Ogura, Katsuya Endo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cellsKonstantinos A Papadakis, John L Prehn, Carol Landers, et al.
Pageof 19